Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Surfeit locus protein 4 (SURF4) is a conserved, polytopic integral membrane protein of approximately 269 amino acids (∼30 kDa) located predominantly in the endoplasmic reticulum (ER)[6]. It functions as a cargo receptor, mediating the selective export of soluble cargo proteins from the ER to the Golgi apparatus via coat protein complex II (COPII)-coated vesicles or tubular carriers[1][2][3][6]. SURF4 recognizes secretory proteins bearing a specific three-amino-acid N-terminal "ER-ESCAPE motif," enabling them to enter the secretory pathway efficiently[1][4][7]. It regulates trafficking and secretion of diverse proteins, notably those implicated in lipid metabolism (such as PCSK9 and very low-density lipoprotein, VLDL), endocrinology (proinsulin, erythropoietin), and cell signaling[1][4][7]. SURF4 is necessary for maintaining ERGIC and Golgi apparatus architecture through multiprotein complexes with other cargo receptors (e.g., ERGIC-53, p24 family members)[5]. Liver-specific knockout of SURF4 reduces plasma lipids and protects against atherosclerosis in mice, indicating its potential as a therapeutic target for metabolic disorders[1][3]. However, broad inhibition may yield wide-reaching effects on general secretion and cell viability[1][3].
For potential future therapies: Inhibition of SURF4 may reduce VLDL secretion and plasma cholesterol, thus reducing atherosclerosis[1][3]. Mechanistically, drugs would likely act by modulating cargo receptor function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Surfeit locus protein 4 (SURF4).